1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zhang X, Li F and Zhu L: Clinical
significance and functions of microRNA-93/CDKN1A axis in human
cervical cancer. Life Sci. 209:242–248. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Zhu X, Zhou L, Li R, Shen Q, Cheng H, Shen
Z and Zhu H: AGER promotes proliferation and migration in cervical
cancer. Biosci Rep. 38:BSR201713292018. View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhu H, Shen Z, Luo H, Zhang W and Zhu X:
Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer:
A Meta-Analysis. Medicine (Baltimore). 95:e30772016. View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhu H, Luo H, Shen Z, Hu X, Sun L and Zhu
X: Transforming growth factor-β1 in carcinogenesis, progression,
and therapy in cervical cancer. Tumour Biol. 37:7075–7083. 2016.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Yang Z, Sun Q, Guo J, Wang S, Song G, Liu
W, Liu M and Tang H: GRSF1-mediated MIR-G-1 promotes malignant
behavior and nuclear autophagy by directly upregulating TMED5 and
LMNB1 in cervical cancer cells. Autophagy. 15:668–685. 2019.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Lin YF, Tsai WP, Liu HG and Liang PH:
Intracellular beta-tubulin/chaperonin containing TCP1-beta complex
serves as a novel chemotherapeutic target against drug-resistant
tumors. Cancer Res. 69:6879–6888. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Vallin J and Grantham J: The role of the
molecular chaperone CCT in protein folding and mediation of
cytoskeleton-associated processes: Implications for cancer cell
biology. Cell Stress Chaperones. 24:17–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
9
|
Klimczak M, Biecek P, Zylicz A and Zylicz
M: Heat shock proteins create a signature to predict the clinical
outcome in breast cancer. Sci Rep. 9:75072019. View Article : Google Scholar : PubMed/NCBI
|
10
|
Park SH, Jeong S, Kim BR, Jeong YA, Kim
JL, Na YJ, Jo MJ, Yun HK, Kim DY, Kim BG, et al: Activating CCT2
triggers Gli-1 activation during hypoxic condition in colorectal
cancer. Oncogene. 39:136–150. 2020. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang L, Zhao H, Li J, Xu Y, Lan Y, Yin W,
Liu X, Yu L, Lin S, Du MY, et al: Identifying functions and
prognostic biomarkers of network motifs marked by diverse chromatin
states in human cell lines. Oncogene. 39:677–689. 2020. View Article : Google Scholar : PubMed/NCBI
|
12
|
Liu P, Kong L, Jin H, Wu Y, Tan X and Song
B: Differential secretome of pancreatic cancer cells in
serum-containing conditioned medium reveals CCT8 as a new biomarker
of pancreatic cancer invasion and metastasis. Cancer Cell Int.
19:2622019. View Article : Google Scholar : PubMed/NCBI
|
13
|
Liu Y, Zhang X, Lin J, Chen Y, Qiao Y, Guo
S, Yang Y, Zhu G, Pan Q, Wang J, et al: CCT3 acts upstream of YAP
and TFCP2 as a potential target and tumour biomarker in liver
cancer. Cell Death Dis. 10:6442019. View Article : Google Scholar : PubMed/NCBI
|
14
|
Qian EN, Han SY, Ding SZ and Lv X:
Expression and diagnostic value of CCT3 and IQGAP3 in
hepatocellular carcinoma. Cancer Cell Int. 16:552016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Shi X, Cheng S and Wang W: Suppression of
CCT3 inhibits malignant proliferation of human papillary thyroid
carcinoma cell. Oncol Lett. 15:9202–9208. 2018.PubMed/NCBI
|
16
|
Cui F, Hu J, Fan Y, Tan J and Tang H:
Knockdown of spindle pole body component 25 homolog inhibits cell
proliferation and cycle progression in prostate cancer. Oncol Lett.
15:5712–5720. 2018.PubMed/NCBI
|
17
|
Wan X, Pu H, Huang W, Yang S, Zhang Y,
Kong Z, Yang Z, Zhao P, Li A, Li T, et al: Androgen-induced
miR-135a acts as a tumor suppressor through downregulating RBAK and
MMP11, and mediates resistance to androgen deprivation therapy.
Oncotarget. 7:51284–51300. 2016. View Article : Google Scholar : PubMed/NCBI
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
19
|
den Boon JA, Pyeon D, Wang SS, Horswill M,
Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, et
al: Molecular transitions from papillomavirus infection to cervical
precancer and cancer: Role of stromal estrogen receptor signaling.
Proc Natl Acad Sci USA. 112:E3255–E3264. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Thomas A, Mahantshetty U, Kannan S,
Deodhar K, Shrivastava SK, Kumar-Sinha C and Mulherkar R:
Expression profiling of cervical cancers in Indian women at
different stages to identify gene signatures during progression of
the disease. Cancer Med. 2:836–848. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Scotto L, Narayan G, Nandula SV,
Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright
JD, Pothuri B, Mansukhani M, et al: Identification of copy number
gain and overexpressed genes on chromosome arm 20q by an
integrative genomic approach in cervical cancer: Potential role in
progression. Genes Chromosomes Cancer. 47:755–765. 2008. View Article : Google Scholar : PubMed/NCBI
|
22
|
Xu G, Bu S, Wang X, Zhang H and Ge H:
Suppression of CCT3 inhibits the proliferation and migration in
breast cancer cells. Cancer Cell Int. 20:2182020. View Article : Google Scholar : PubMed/NCBI
|
23
|
Dun MD, Smith ND, Baker MA, Lin M, Aitken
RJ and Nixon B: The chaperonin containing TCP1 complex (CCT/TRiC)
is involved in mediating sperm-oocyte interaction. J Biol Chem.
286:36875–36887. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Nadler-Holly M, Breker M, Gruber R, Azia
A, Gymrek M, Eisenstein M, Willison KR, Schuldiner M and Horovitz
A: Interactions of subunit CCT3 in the yeast chaperonin CCT/TRiC
with Q/N-rich proteins revealed by high-throughput microscopy
analysis. Proc Natl Acad Sci USA. 109:18833–18838. 2012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Syed A, Lukacsovich T, Pomeroy M, Bardwell
AJ, Decker GT, Waymire KG, Purcell J, Huang W, Gui J, Padilla EM,
et al: Miles to go (mtgo) encodes FNDC3 proteins that interact with
the chaperonin subunit CCT3 and are required for NMJ branching and
growth in Drosophila. Dev Biol. 445:37–53. 2019. View Article : Google Scholar : PubMed/NCBI
|
26
|
Yao L, Zou X and Liu L: The TCP1 ring
complex is associated with malignancy and poor prognosis in
hepatocellular carcinoma. Int J Clin Exp Pathol. 12:3329–3343.
2019.PubMed/NCBI
|
27
|
Carr AC, Khaled AS, Bassiouni R, Flores O,
Nierenberg D, Bhatti H, Vishnubhotla P, Manuel JP, Santra S and
Khaled AR: Targeting chaperonin containing TCP1 (CCT) as a
molecular therapeutic for small cell lung cancer. Oncotarget.
8:110273–110288. 2017. View Article : Google Scholar : PubMed/NCBI
|
28
|
Qiu X, He X, Huang Q, Liu X, Sun G, Guo J,
Yuan D, Yang L, Ban N, Fan S, et al: Overexpression of CCT8 and its
significance for tumor cell proliferation, migration and invasion
in glioma. Pathol Res Pract. 211:717–725. 2015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Nibbe RK, Markowitz S, Myeroff L, Ewing R
and Chance MR: Discovery and scoring of protein interaction
subnetworks discriminative of late stage human colon cancer. Mol
Cell Proteomics. 8:827–845. 2009. View Article : Google Scholar : PubMed/NCBI
|
30
|
Wang J, Deng L, Huang J, Cai R, Zhu X, Liu
F, Wang Q, Zhang J and Zheng Y: High expression of Fibronectin 1
suppresses apoptosis through the NF-κB pathway and is associated
with migration in nasopharyngeal carcinoma. Am J Transl Res.
9:4502–4511. 2017.PubMed/NCBI
|
31
|
Li B, Shen W, Peng H, Li Y, Chen F, Zheng
L, Xu J and Jia L: Fibronectin 1 promotes melanoma proliferation
and metastasis by inhibiting apoptosis and regulating EMT.
OncoTargets Ther. 12:3207–3221. 2019. View Article : Google Scholar : PubMed/NCBI
|
32
|
Soikkeli J, Podlasz P, Yin M, Nummela P,
Jahkola T, Virolainen S, Krogerus L, Heikkilä P, von Smitten K,
Saksela O, et al: Metastatic outgrowth encompasses COL-I, FN1, and
POSTN up-regulation and assembly to fibrillar networks regulating
cell adhesion, migration, and growth. Am J Pathol. 177:387–403.
2010. View Article : Google Scholar : PubMed/NCBI
|
33
|
Cai X, Liu C, Zhang TN, Zhu YW, Dong X and
Xue P: Down-regulation of FN1 inhibits colorectal carcinogenesis by
suppressing proliferation, migration, and invasion. J Cell Biochem.
119:4717–4728. 2018. View Article : Google Scholar : PubMed/NCBI
|
34
|
Yang X, Hu Q, Hu LX, Lin XR, Liu JQ, Lin
X, Dinglin XX, Zeng JY, Hu H, Luo ML, et al: miR-200b regulates
epithelial-mesenchymal transition of chemo-resistant breast cancer
cells by targeting FN1. Discov Med. 24:75–85. 2017.PubMed/NCBI
|
35
|
Wang Y, Huang L, Wu S, Jia Y, Yang Y, Luo
L, Bi A and Fang M: Bioinformatics analyses of the role of vascular
endothelial growth factor in patients with non-small cell lung
cancer. PLoS One. 10:e01392852015. View Article : Google Scholar : PubMed/NCBI
|
36
|
Balasubramaniam SD, Balakrishnan V, Oon CE
and Kaur G: Key molecular events in cervical cancer development.
Medicina (Kaunas). 55:3842019. View Article : Google Scholar : PubMed/NCBI
|
37
|
Nero C, Ciccarone F, Pietragalla A and
Scambia G: PTEN and Gynecological cancers. Cancers (Basel).
11:14582019. View Article : Google Scholar : PubMed/NCBI
|